Huntsville, Alabama (May 21, 2024)) – Curiteva, Inc. today announced the addition of Chris Schultz as vice president of marketing to the fast-growing technology company headquartered in Huntsville, Alabama. The addition is part of a recently launched strategy to strengthen the company's brand and propel Curiteva to the next level of innovation and growth. This effort aligns with the company's ongoing innovation efforts, marked by the ongoing introduction of products powered by its transformative Inspire Technology.
Mr. Schultz has over 17 years of extensive clinical, marketing and leadership experience in the spine industry. Prior to joining Curiteva, Ms. Schultz honed her expertise for 10 years as a spine specialist at Nuvasive and then held advanced marketing roles at Integrity Implants. Most recently, she served as Senior Director of Product Management at Accelus, where she was responsible for helping drive the company's marketing strategy, growth initiatives, and market penetration efforts.
“Chris is a talented and experienced leader in our industry, and we are honored to have him join the Clyteva team,” said David Schmidt, chief commercial officer. “His expertise will be instrumental as we continue to innovate and bring to market transformative technologies to meet the evolving needs of our customers and their patients.”
Mr. Schultz will be responsible for developing and executing strategic marketing plans, building brand awareness and driving market adoption.
“Curiteva is poised to set new standards for how implants are constructed and ultimately accepted by patients. We are very proud of the Curiteva brand, its employees, core products, and Inspire Technology. The future is bright and I am honored and excited to be a part of the team. I look forward to helping lead this transformational company and its technology.” .
About Kriteva:
Curiteva is a privately held technology and manufacturing company based in Huntsville, Alabama. Our business is built on a commitment to building world-class manufacturing, accelerating research and development, maintaining lean operational discipline, and delivering new technologies to meet the evolving needs of our customers and patients. Curiteva is pioneering the 3D printing of trabecular PEEK implants with bioactive nanosurfaces, revolutionizing how engineered structures and implant biomaterials can promote immunomodulation, promote healing, and improve patient outcomes. brings. For more information, please visit www.curiteva.com.
